Medical Devices

Exiting stealth, PerturbAI releases an 8-million-cell map of gene function in a living brain, aiming to slash the cost and time of creating new drugs.

BioCardia's FDA milestone for its Helix catheter could unlock a new era of targeted heart therapies, but financial hurdles and clinical questions remain.

A new telehealth model challenges the prescription-first approach, combining GLP-1s with 24/7 clinical support. Is this the future of metabolic health?

Princess Padmaja Kumari Parmar receives the Mary Tyler Moore Award for her advocacy, bridging a legacy of hope with a modern fight for global T1D equity.

A new exoskeleton, validated by scientific studies, shows a dramatic reduction in muscle strain and discomfort for surgeons, dentists, and industrial workers.

Regulatory pressure ends a major ophthalmic deal, forcing LENSAR to forge ahead alone with its ALLY system and a $10M deposit. What's next?

Facing a challenging EV market, Aspen Aerogels looks to the Roth Conference to showcase its long-term growth strategy and advanced aerogel technology.

Riding a wave of record revenue and a new product launch, iRadimed showcases its MRI-compatible device dominance to investors, aiming to fuel future growth.

As essential pediatric care costs skyrocket, families of children with cerebral palsy face a silent crisis of debt, stress, and impossible choices.

The global manufacturer's latest acquisition adds key blow molding capabilities and expands its U.S. footprint, signaling a major push into the medical sector.

Facing critical staff shortages, Rochester Regional Health offers up to $180,000 in loan relief to secure vital healthcare roles for the community.

A new study at GBMC tests an AI-powered artificial larynx, offering hope to millions of voiceless ICU patients and aiming to transform critical care.

With a new CEO known for successful exits and a breakthrough PFA system for complex arrhythmias, Field Medical is poised to disrupt the cardiac ablation market.

The spinal device firm will meet investors at the key small-cap conference, balancing a story of innovation against mixed financial results.

With its lead autoimmune drug nearing FDA review and a new $250M in funding, Zenas BioPharma prepares for a major leap from R&D to market.

Nasus Pharma's NS002 nasal spray reached critical therapeutic levels in half the time of EpiPen, heralding a potential new era for anaphylaxis treatment.

As MediciNova execs meet investors at the ROTH Conference, all eyes are on pivotal updates for its ALS, MS, and NAFLD drug candidates.

Riyadh's KFSH performed 130 paired kidney transplants in 2025, the most by any single center worldwide, revolutionizing access to organ donation.

Florida-based 26Health acquires Optimal Integrative Care, signaling a strategic expansion into Atlanta's competitive healthcare market. What does this mean?

A new report projects massive growth in cardiovascular devices, driven by AI and minimally invasive tech. But can the healthcare system afford this progress?